TARGET-IBD Poster & Oral Presentation at ECCO
ECCO Portal
Conference Highlights - ECCO 2020: subcutaneous-vedolizumab-maintenance-therapy-in-cd
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study | Pharmacogenomics
Therapeutic targets in inflammatory bowel disease | Revista Médica Clínica Las Condes
Education
New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) | Business Wire
Novel Analgesics with Peripheral Targets | SpringerLink
PDF) ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
PPT - A Report from ECCO 14 Oral Chemotherapy in Colorectal Cancer PowerPoint Presentation - ID:3575065
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease - Clinical Gastroenterology and Hepatology
ECCO News 3/2018
Objective evaluation for treat to target in Crohn's disease | SpringerLink
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis - Allen - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
PDF) ECCO2R therapy in the ICU: consensus of a European round table meeting
Geox case analysis
Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease - Day - 2020 - JGH Open - Wiley Online Library
3D TARGET SRL | LinkedIn
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say? | SpringerLink
PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease
